ID   KGP_PLAVS               Reviewed;         846 AA.
AC   A5K0N4;
DT   10-FEB-2021, integrated into UniProtKB/Swiss-Prot.
DT   10-JUL-2007, sequence version 1.
DT   07-APR-2021, entry version 97.
DE   RecName: Full=cGMP-dependent protein kinase {ECO:0000305};
DE            EC=2.7.11.12 {ECO:0000250|UniProtKB:Q8I719};
GN   Name=PKG {ECO:0000305}; ORFNames=PVX_084705 {ECO:0000312|EMBL:EDL46881.1};
OS   Plasmodium vivax (strain Salvador I).
OC   Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC   Plasmodiidae; Plasmodium; Plasmodium (Plasmodium).
OX   NCBI_TaxID=126793 {ECO:0000312|Proteomes:UP000008333};
RN   [1] {ECO:0000312|Proteomes:UP000008333}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Salvador I {ECO:0000312|Proteomes:UP000008333};
RX   PubMed=18843361; DOI=10.1038/nature07327;
RA   Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E.,
RA   Crabtree J., Angiuoli S.V., Merino E.F., Amedeo P., Cheng Q.,
RA   Coulson R.M.R., Crabb B.S., del Portillo H.A., Essien K., Feldblyum T.V.,
RA   Fernandez-Becerra C., Gilson P.R., Gueye A.H., Guo X., Kang'a S.,
RA   Kooij T.W.A., Korsinczky M., Meyer E.V.-S., Nene V., Paulsen I., White O.,
RA   Ralph S.A., Ren Q., Sargeant T.J., Salzberg S.L., Stoeckert C.J.,
RA   Sullivan S.A., Yamamoto M.M., Hoffman S.L., Wortman J.R., Gardner M.J.,
RA   Galinski M.R., Barnwell J.W., Fraser-Liggett C.M.;
RT   "Comparative genomics of the neglected human malaria parasite Plasmodium
RT   vivax.";
RL   Nature 455:757-763(2008).
RN   [2] {ECO:0007744|PDB:4RZ7, ECO:0007744|PDB:5EZR, ECO:0007744|PDB:5F0A, ECO:0007744|PDB:5FET}
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) IN COMPLEX WITH INHIBITORS.
RX   PubMed=28874661; DOI=10.1038/s41467-017-00572-x;
RA   Baker D.A., Stewart L.B., Large J.M., Bowyer P.W., Ansell K.H.,
RA   Jimenez-Diaz M.B., El Bakkouri M., Birchall K., Dechering K.J.,
RA   Bouloc N.S., Coombs P.J., Whalley D., Harding D.J., Smiljanic-Hurley E.,
RA   Wheldon M.C., Walker E.M., Dessens J.T., Lafuente M.J., Sanz L.M.,
RA   Gamo F.J., Ferrer S.B., Hui R., Bousema T., Angulo-Barturen I.,
RA   Merritt A.T., Croft S.L., Gutteridge W.E., Kettleborough C.A.,
RA   Osborne S.A.;
RT   "A potent series targeting the malarial cGMP-dependent protein kinase
RT   clears infection and blocks transmission.";
RL   Nat. Commun. 8:430-430(2017).
RN   [3] {ECO:0007744|PDB:5DYL, ECO:0007744|PDB:5DZC}
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) IN COMPLEX WITH ATP ANALOG.
RX   PubMed=31239348; DOI=10.1073/pnas.1905558116;
RA   El Bakkouri M., Kouidmi I., Wernimont A., Amani M., Hutchinson A.,
RA   Loppnau P., Kim J.J., Flueck C., Walker J.R., Seitova A., Senisterra G.,
RA   Kakihara Y., Kim C., Blackman M.J., Calmettes C., Baker D.A., Hui R.;
RT   "Structures of the cGMP-dependent protein kinase in malaria parasites
RT   reveal a unique structural relay mechanism for activation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 116:14164-14173(2019).
CC   -!- FUNCTION: Serine/threonine protein kinase which acts as a downstream
CC       effector of the second messenger cGMP. Controls the release of Ca(2+)
CC       from intracellular stores by regulating phosphoinositide biosynthesis.
CC       Ca(2+) signals are essential for merozoite and sporozoite invasion and
CC       egress from host hepatocytes and erythrocytes, and, in the mosquito
CC       vector, for gametocyte activation, and ookinete and sporozoite motility
CC       (By similarity). During the host liver stage, regulates the initial
CC       invasion of host hepatocytes by sporozoites by regulating sporozoite
CC       motility and microneme exocytosis. Following parasite development in
CC       the hepatocytes, required for the release of merosomes, a vesicle
CC       containing the mature merozoites (By similarity). During the asexual
CC       blood stage, required for the progression from schizont to the ring
CC       stage following merozoite invasion of host erythrocytes and for
CC       merozoite egress. Regulates merozoite egress by promoting the release
CC       of exonemes and micronemes which contain proteins essential for egress.
CC       Phosphorylates CDPK1 predominantly at the late schizont stage;
CC       phosphorylation at 'Ser-64' regulates CDPK1 protein-protein interaction
CC       and phosphorylation at 'Thr-231' may regulate CDPK1 kinase activity. In
CC       the mosquito vector, required for the initiation of gametogenesis
CC       induced by xanthurenic acid, specifically the gametocyte
CC       differentiation from the crecsent-shaped form to the spherical form (By
CC       similarity). Required for the gliding motility of ookinetes to reach
CC       and penetrate the midgut epithelium by promoting Ca(2+)-mediated
CC       activation of CDPK1 and CDPK4. Also required for microneme secretion in
CC       ookinete by promoting Ca(2+)-mediated activation of CDPK3 (By
CC       similarity). {ECO:0000250|UniProtKB:A0A509AKL0,
CC       ECO:0000250|UniProtKB:Q8I719}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.12;
CC         Evidence={ECO:0000250|UniProtKB:Q8I719};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.12; Evidence={ECO:0000250|UniProtKB:Q8I719};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q8I719};
CC   -!- ACTIVITY REGULATION: Activated by cGMP. Not activated by cAMP. cGMP
CC       binding allosterically triggers a conformational change at the alpha C-
CC       helix of cGMP-binding domain 4, which bridges the regulatory and
CC       catalytic domains, causing the capping triad, composed of Arg-477, Gln-
CC       525 and Asp-526, to form and stabilize the active conformation. The
CC       cGMP-binding domains acts cooperatively to activate PKG.
CC       {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q8I719}.
CC       Endoplasmic reticulum membrane {ECO:0000250|UniProtKB:Q8I719};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q8I719}; Cytoplasmic
CC       side {ECO:0000250|UniProtKB:Q8I719}. Note=Predominantly localizes to
CC       the cytoplasm during schizogony. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- DOMAIN: The cGMP-binding domains 1, 2 and 4 bind preferentially cGMP.
CC       The cGMP-binding domain 4 binds cGMP with the highest affinity and is
CC       highly selective for cGMP. The cGMP-binding domain 3 does not bind cGMP
CC       but is required for cGMP-dependent catalytic activity. The cGMP-binding
CC       domains 1, 2 and 4 can bind cAMP but with less affinity.
CC       {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- DOMAIN: The autoinhibitory segment (AIS) interacts with the active site
CC       and inhibits catalytic activity. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250|UniProtKB:Q8I719}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cGMP subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AAKM01000002; EDL46881.1; -; Genomic_DNA.
DR   RefSeq; XP_001616608.1; XM_001616558.1.
DR   PDB; 4RZ7; X-ray; 2.35 A; A=1-846.
DR   PDB; 5DYL; X-ray; 2.40 A; A=1-846.
DR   PDB; 5DZC; X-ray; 2.30 A; A=1-846.
DR   PDB; 5EZR; X-ray; 2.50 A; A=1-846.
DR   PDB; 5F0A; X-ray; 2.60 A; A=1-846.
DR   PDB; 5FET; X-ray; 3.07 A; A=1-846.
DR   PDBsum; 4RZ7; -.
DR   PDBsum; 5DYL; -.
DR   PDBsum; 5DZC; -.
DR   PDBsum; 5EZR; -.
DR   PDBsum; 5F0A; -.
DR   PDBsum; 5FET; -.
DR   SMR; A5K0N4; -.
DR   EnsemblProtists; EDL46881; EDL46881; PVX_084705.
DR   GeneID; 5475916; -.
DR   KEGG; pvx:PVX_084705; -.
DR   VEuPathDB; PlasmoDB:PVX_084705; -.
DR   InParanoid; A5K0N4; -.
DR   OMA; ESCLADC; -.
DR   Proteomes; UP000008333; Chromosome 13.
DR   Proteomes; UP000008333; Unassembled WGS sequence.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030553; F:cGMP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004692; F:cGMP-dependent protein kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0106311; F:protein threonine kinase activity; IEA:RHEA.
DR   CDD; cd00038; CAP_ED; 3.
DR   CDD; cd05572; STKc_cGK; 1.
DR   Gene3D; 2.60.120.10; -; 4.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR002374; cGMP_dep_kinase.
DR   InterPro; IPR018490; cNMP-bd-like.
DR   InterPro; IPR018488; cNMP-bd_CS.
DR   InterPro; IPR000595; cNMP-bd_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014710; RmlC-like_jellyroll.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR035014; STKc_cGK.
DR   Pfam; PF00027; cNMP_binding; 3.
DR   Pfam; PF00069; Pkinase; 1.
DR   PIRSF; PIRSF000559; cGMP-dep_kinase; 1.
DR   SMART; SM00100; cNMP; 4.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF51206; SSF51206; 4.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00888; CNMP_BINDING_1; 3.
DR   PROSITE; PS00889; CNMP_BINDING_2; 3.
DR   PROSITE; PS50042; CNMP_BINDING_3; 4.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; cGMP; cGMP-binding; Cytoplasm;
KW   Endoplasmic reticulum; Kinase; Magnesium; Membrane; Metal-binding;
KW   Nucleotide-binding; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..846
FT                   /note="cGMP-dependent protein kinase"
FT                   /id="PRO_0000451909"
FT   DOMAIN          534..791
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          792..846
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   NP_BIND         51..166
FT                   /note="3',5'-cGMP 1; low affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         169..268
FT                   /note="3',5'-cGMP 1; low affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         288..391
FT                   /note="3',5'-cGMP 3; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         411..510
FT                   /note="3',5'-cGMP 4; high affinity"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00060"
FT   NP_BIND         540..548
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..22
FT                   /note="Autoinhibitory segment"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
FT   ACT_SITE        657
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         563
FT                   /note="ATP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000269|PubMed:31239348, ECO:0007744|PDB:5DZC"
FT   SITE            477
FT                   /note="Part of a catalytic triad required for cGMP binding
FT                   and cGMP-dependent kinase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
FT   SITE            525
FT                   /note="Part of a catalytic triad required for cGMP binding
FT                   and cGMP-dependent kinase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
FT   SITE            526
FT                   /note="Part of a catalytic triad required for cGMP binding
FT                   and cGMP-dependent kinase activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8I719"
SQ   SEQUENCE   846 AA;  96548 MW;  F4816715FBBB8211 CRC64;
     MRCNERNKKK AIFSNDDFSG EDTLMEDHLQ LREKLSEDIE MIKASLKNNL VCSTLNDNEI
     LTLSNYMQFF VFKGGDLVIK QGEKGSYFFI INSGKFDVYV NDKKVKSMGK GSSFGEAALI
     HNTQRSATIM AETDGTLWGV QRSTFRATLK QLSNRNFNEN RSFIDSVSVF DMLTEAQKNM
     ITNACVIQMF KPGETIVKQG DYGDVLFILK EGKATVFIND KEIRVLNKGS YFGERALLYD
     EPRSATIIAK EPTACASICR KLLNIVLGNL QVVLFRNIMT EALQQSEIFR QFSAEQLNDL
     ADTAIVRDYP ANYHILHKDK VKSVKYLIVL EGKVELFLDD ESIGILTRGK SFGDQYVLNQ
     KQKFRHTVKS LDVCKIALIT ESCLADCLGD NNIDASIDHN NKKSIIKKMY IFRYLSEQQC
     NLLIEAFRTT RYEEGDYIIQ EGEVGSRFYI IKNGEVEVTK NGKRLRTLGK NDYFGERALL
     YDEPRTASII SKATSVECWF VDKSVFLQII QGPMLTHLEE RIKMQDTKVE MHELETERII
     GRGTFGTVKL VHHKPTQIRY ALKCVSKRSI ISLNQQNNIK LEREITAEND HPFIIRLVRT
     FKDSNCFYFL TELVTGGELY DAIRKLGLLS KPQAQFYLGS IILAIEYLHE RNIVYRDLKP
     ENILLDKQGY VKLIDFGCAK KIQGRAYTLV GTPHYMAPEV ILGKGYGCTV DIWALGVCLY
     EFICGPLPFG NDQEDQLEIF RDILTGQLTF PDYVSDQDSI NLMKRLLCRL PQGRIGCSIN
     GFKDIKEHAF FGNFNWDKLA GRLLEPPLVS KGETYAEDID IKQIEEEDAL NEGEPLDGDD
     SWDVDF
//
